Published in Thorax on October 01, 1999
Comparison of Airway and Systemic Malondialdehyde Levels for Assessment of Oxidative Stress in Cystic Fibrosis. Lung (2015) 2.00
Heme oxygenase-1 and carbon monoxide in pulmonary medicine. Respir Res (2003) 1.33
Increased blood carboxyhaemoglobin concentrations in inflammatory pulmonary diseases. Thorax (2002) 1.02
Exhaled breath measures of inflammation: are they useful in neonatal chronic lung disease? Arch Dis Child Fetal Neonatal Ed (2005) 1.02
Increase in exhaled carbon monoxide during exacerbations of cystic fibrosis. Thorax (2000) 0.98
Comparison of exhaled and nasal nitric oxide and exhaled carbon monoxide levels in bronchiectatic patients with and without primary ciliary dyskinesia. Thorax (2003) 0.95
Effect of carbon monoxide on Mycobacterium tuberculosis pathogenesis. Med Gas Res (2012) 0.94
Exhaled carbon monoxide levels in children with sickle cell disease. Eur J Pediatr (2004) 0.91
cor, a novel carbon monoxide resistance gene, is essential for Mycobacterium tuberculosis pathogenesis. MBio (2013) 0.86
Carbon monoxide in exhaled breath testing and therapeutics. J Breath Res (2013) 0.84
Exhaled breath analysis: from occupational to respiratory medicine. Acta Biomed (2005) 0.83
Noninvasive effects measurements for air pollution human studies: methods, analysis, and implications. J Expo Sci Environ Epidemiol (2015) 0.79
Therapeutic applications of carbon monoxide. Oxid Med Cell Longev (2013) 0.78
Effects of acute hypoventilation and hyperventilation on exhaled carbon monoxide measurement in healthy volunteers. BMC Pulm Med (2009) 0.78
Breath tests in respiratory and critical care medicine: from research to practice in current perspectives. Biomed Res Int (2013) 0.75
Multicomponent Breath Analysis With Infrared Absorption Using Room-Temperature Quantum Cascade Lasers. IEEE Sens J (2009) 0.75
Inflammatory markers: exhaled nitric oxide and carbon monoxide during the ovarian cycle. Inflammation (2012) 0.75
Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med (1995) 6.56
Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell (1993) 6.25
Increased nitric oxide in exhaled air of asthmatic patients. Lancet (1994) 5.39
Regulation of biosynthesis of nitric oxide. J Biol Chem (1994) 4.82
Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest (1992) 3.50
Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am J Respir Cell Mol Biol (1996) 3.49
Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med (1995) 3.47
Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force. Eur Respir J (1997) 2.79
Induction of heme oxygenase: a general response to oxidant stress in cultured mammalian cells. Cancer Res (1991) 2.30
Nitric oxide and asthmatic inflammation. Immunol Today (1995) 2.01
Systemic deficiency of glutathione in cystic fibrosis. J Appl Physiol (1985) (1993) 1.88
Nitric oxide metabolites in cystic fibrosis lung disease. Arch Dis Child (1998) 1.76
Elevated levels of exhaled nitric oxide in bronchiectasis. Am J Respir Crit Care Med (1995) 1.67
Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide. Am J Respir Crit Care Med (1995) 1.67
Altered antioxidant status and increased lipid peroxidation in children with cystic fibrosis. Am J Clin Nutr (1995) 1.65
Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract. Am J Respir Crit Care Med (1996) 1.65
Hemoglobin provides protection against lethal endotoxemia in rats: the role of heme oxygenase-1. Am J Respir Cell Mol Biol (1995) 1.63
Reduced upper airway nitric oxide in cystic fibrosis. Arch Dis Child (1996) 1.50
Hypoalbuminemia at initial examination in patients with cystic fibrosis. J Pediatr (1989) 1.45
Exhaled nitric oxide in paediatric asthma and cystic fibrosis. Arch Dis Child (1996) 1.42
Loss and degradation of enzyme-bound heme induced by cellular nitric oxide synthesis. J Biol Chem (1995) 1.41
Interleukin-1 and tumour necrosis factor induce hepatic haem oxygenase. Feedback regulation by glucocorticoids. Biochem J (1991) 1.40
Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Circ Res (1997) 1.39
Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide. Thorax (1998) 1.34
Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis. J Pathol (1998) 1.34
Oxidant stress leads to transcriptional activation of the human heme oxygenase gene in cultured skin fibroblasts. Mol Cell Biol (1990) 1.29
Airway nitric oxide in asthmatic children and patients with cystic fibrosis. Eur Respir J (1996) 1.24
Increased levels of interleukin-1 in bronchoalveolar washings from children with bacterial pulmonary infections. Am Rev Respir Dis (1990) 1.21
Pulmonary oxidative stress response in young children with cystic fibrosis. Thorax (1997) 1.18
Neutrophil-derived long-lived oxidants in cystic fibrosis sputum. Am J Respir Crit Care Med (1995) 1.17
Brain nitric oxide synthase is a haemoprotein. Biochem J (1992) 1.13
How the cell copes with stress and the function of heat shock proteins. Pediatr Res (1994) 1.00
Symptomatic vitamin E deficiency in cystic fibrosis. Arch Dis Child (1985) 0.99
Calcium metabolism and cystic fibrosis: mitochondrial abnormalities suggest a modification of the mitochondrial membrane. Pediatr Res (1984) 0.95
Downregulation of the human heme oxygenase gene by glucocorticoids and identification of 56b regulatory elements. Biochem Biophys Res Commun (1996) 0.94
Anti-inflammatory therapy for asthma. Annu Rev Med (1993) 0.93
Catalase, myeloperoxidase and hydrogen peroxide in cystic fibrosis. Eur Respir J (1998) 0.87
Glucocorticoids inhibit superoxide anion production and p22 phox mRNA expression in human aortic smooth muscle cells. Hypertension (1998) 0.86
Effect of inhaled glucocorticoid on the cellular profile and cytokine levels in induced sputum from asthmatic patients. Lung (1999) 0.85
Iron deficiency in cystic fibrosis. Arch Dis Child (1987) 0.84
The role of carbon monoxide in lucigenin-dependent chemiluminescence of rat alveolar macrophages. Eur J Pharmacol (1995) 0.79
Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J (2008) 10.08
Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med (1997) 8.48
Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med (1996) 5.53
Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med (2001) 5.47
Increased nitric oxide in exhaled air of asthmatic patients. Lancet (1994) 5.39
Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J (2008) 5.38
Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet (2001) 5.25
Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J (2005) 5.24
Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (Lond) (1998) 4.31
Results from CMA's huge 1998 physician survey point to a dispirited profession. CMAJ (1998) 4.08
Make helmet use mandatory for all bicyclists, CMA recommends. CMAJ (1992) 4.08
A population-based twin study in women of smoking initiation and nicotine dependence. Psychol Med (1999) 3.78
Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nat Med (1995) 3.61
Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial. Lancet (2001) 3.48
Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med (1999) 3.44
Learning curves for endobronchial ultrasound using cusum analysis. Thorax (2010) 3.34
Identification of the cystic fibrosis gene. BMJ (1990) 3.28
Independent genetic determinants of pancreatic and pulmonary status in cystic fibrosis. Lancet (1990) 3.27
Family medicine loses lustre as students "vote with feet" in 2001 residency match. CMAJ (2001) 3.26
Asthma as an axon reflex. Lancet (1986) 3.26
Single-dose slow-release aminophylline at night prevents nocturnal asthma. Lancet (1982) 3.21
Exhaled markers of pulmonary disease. Am J Respir Crit Care Med (2001) 3.14
Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Respir J (2000) 3.14
Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol (2000) 3.13
Q fever endocarditis treated with trimethoprim and sulphamethoxazole. Br Med J (1972) 3.06
Neural control of human airways in health and disease. Am Rev Respir Dis (1986) 2.97
Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis. Lancet (1981) 2.87
Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force. Eur Respir J (1997) 2.79
Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med (1997) 2.77
Liver disease and bile duct abnormalities in adults with cystic fibrosis. Lancet (1989) 2.76
Measles vaccination and antibody response in autism spectrum disorders. Arch Dis Child (2008) 2.71
Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax (1998) 2.71
The relationship of phenotype changes in Pseudomonas aeruginosa to the clinical condition of patients with cystic fibrosis. Am Rev Respir Dis (1983) 2.68
Exacerbations of chronic obstructive pulmonary disease. Eur Respir J (2007) 2.65
Bradykinin-induced bronchoconstriction in humans. Mode of action. Am Rev Respir Dis (1987) 2.64
Cytokines in asthma. Thorax (1999) 2.64
High-dose beclomethasone inhaler in the treatment of asthma. Lancet (1983) 2.58
Wasting as an independent predictor of mortality in patients with cystic fibrosis. Thorax (2001) 2.50
Cystic fibrosis in adolescents and adults. Thorax (1987) 2.47
Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man. Lancet (1986) 2.41
Effects of long term inhaled high dose beclomethasone dipropionate on adrenal function. Thorax (1983) 2.35
Concerns about size of MD workforce, medicine's future dominate CMA annual meeting. CMAJ (1999) 2.33
Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med (2000) 2.33
Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med (1996) 2.32
Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma. N Engl J Med (1992) 2.32
Acute and chronic effects of cigarette smoking on exhaled nitric oxide. Am J Respir Crit Care Med (1995) 2.28
Circulating catecholamines in exercise and hyperventilation induced asthma. Thorax (1981) 2.22
Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. Mol Psychiatry (2010) 2.21
Exhaled carbon monoxide in childhood asthma. J Pediatr (1999) 2.19
Activation and localization of transcription factor, nuclear factor-kappaB, in asthma. Am J Respir Crit Care Med (1998) 2.19
Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. FASEB J (2001) 2.18
Parameters associated with persistent airflow obstruction in chronic severe asthma. Eur Respir J (2004) 2.18
Prevention of traveler's diarrhea (emporiatric enteritis). Prophylactic administration of subsalicylate bismuth). JAMA (1980) 2.16
Evaluation of the forced expiration technique as an adjunct to postural drainage in treatment of cystic fibrosis. Br Med J (1979) 2.15
Community exposure to hazardous waste disposal sites: assessing reporting bias. Am J Epidemiol (1985) 2.12
A prognostic model for the prediction of survival in cystic fibrosis. Thorax (1997) 2.10
Cryobiopsy increases the diagnostic yield of endobronchial biopsy: a multicentre trial. Eur Respir J (2011) 2.09
Plastic surgeons take advantage of relaxed rules, launch ad campaigns. CMAJ (1992) 2.06
STAT4 activation in smokers and patients with chronic obstructive pulmonary disease. Eur Respir J (2004) 2.06
Dubin calls on CMPA to eliminate fee differentials, adopt flat fee for all physicians. CMAJ (1997) 2.04
Sports MDs seek CMA support in bid to make hockey safer. CMAJ (1990) 2.04
Increased expression of nuclear factor-kappaB in bronchial biopsies from smokers and patients with COPD. Eur Respir J (2002) 2.04
Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med (2000) 2.03
For first time, unemployment line awaits group of new Canadian specialists. CMAJ (1997) 2.03
Meconium ileus equivalent in adults with cystic fibrosis of pancreas: a report of six cases. Br Med J (1976) 2.02
Management of pneumothorax in adults with cystic fibrosis. Thorax (1982) 1.99
The effect of airway epithelium on smooth muscle contractility in bovine trachea. Br J Pharmacol (1985) 1.98
Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration. Biochem Biophys Res Commun (2004) 1.98
Meta-analysis of genome-wide association studies for personality. Mol Psychiatry (2010) 1.96
Expression of inducible nitric oxide in human lung epithelial cells. Biochem Biophys Res Commun (1994) 1.96
Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. Am J Respir Crit Care Med (1999) 1.96
Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 1.94
Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med (1999) 1.92
Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. Am J Respir Crit Care Med (1997) 1.91
A calcium antagonist, nifedipine, modifies exercise-induced asthma. Thorax (1981) 1.90
Autoradiographic visualization of beta-adrenoceptor subtypes in human lung. Am Rev Respir Dis (1985) 1.89
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. Clin Exp Immunol (2009) 1.89
Sonography in the diagnosis of carpal tunnel syndrome. AJR Am J Roentgenol (1999) 1.87
Tumor necrosis factor-alpha increases airway responsiveness and sputum neutrophilia in normal human subjects. Am J Respir Crit Care Med (1995) 1.84
A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. N Engl J Med (1997) 1.84
Occurrence of Giardia lamblia in children in day care centers. J Pediatr (1984) 1.82
Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone. Br J Pharmacol (1994) 1.82
Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections. Eur Respir J (1995) 1.80
Autoantibodies against bactericidal/permeability-increasing protein in patients with cystic fibrosis. QJM (1996) 1.78
Leukocyte gene expression signatures in antineutrophil cytoplasmic autoantibody and lupus glomerulonephritis. Kidney Int (2007) 1.77
Brittle asthma. Thorax (1998) 1.77
Importance of inhaler devices in the management of airway disease. Respir Med (2007) 1.76
Evidence for systemic rather than pulmonary effects of interleukin-5 administration in asthma. Thorax (2001) 1.76
Malignant mesothelioma of the pleura: relation between histological type and clinical behaviour. Thorax (1982) 1.76
Long term venous access using a totally implantable drug delivery system in patients with cystic fibrosis and bronchiectasis. Respir Med (1989) 1.75
Airway inflammation after controlled exposure to diesel exhaust particulates. Am J Respir Crit Care Med (2000) 1.75
Improved survival at low lung function in cystic fibrosis: cohort study from 1990 to 2007. BMJ (2011) 1.74